Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Atherosclerosis
Research
Scribe eyes clinic as CRISPR candidates lower lipids in animals
One dose of the biotech's lead gene silencer lowered levels of bad cholesterol in macaques by more than 50% for more than 515 days.
Darren Incorvaia
Nov 17, 2025 9:22am
Former Pfizer antibody reduces cardio risk marker in ph. 2
May 20, 2025 7:30am
Repair licenses Genevant's tech for up to $107M per product
Sep 26, 2024 2:53pm
Chasing Merck, AstraZeneca's PCSK9 inhibitor lowers cholesterol
May 29, 2024 11:00am
Arrowhead's cholesterol drug hits the mark again in ph. 2 trial
May 28, 2024 9:13am
AstraZeneca drug once tested for cancer slows atherosclerosis
Jun 9, 2023 7:40am
